Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
First Tracks Biotherapeutics, Inc. (TRAX), most recent 12 months reported: net loss $166.09M, free cash flow -$143.01M. Latest balance sheet on file: liquid cash $168.02M. From SEC filings. Others in Pharmaceutical Preparations: Telomir Pharmaceuticals, Inc. · TENAX THERAPEUTICS, INC. · Theriva Biologics, Inc. · Tempest Therapeutics, Inc. · TRAFALGAR INTERNATIONAL, INC. · Trevi Therapeutics, Inc. · Turn Therapeutics Inc. · TVARDI THERAPEUTICS, INC.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.